Genelux CorpGNLX
Price$2.52

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $8K0.0% YoYTTM through 30 Jun 2026
Net Income -$35.6MTTM through 30 Jun 2026
Free Cash Flow -$28.7MTTM through 30 Jun 2026

Margins

Current
Operating Margin-455,275.0%
Net Margin-444,950.0%

Returns

-220.9%ROE
-168.9%ROA

Balance Sheet Health

Debt / Equity0.00x
Current Ratio2.43x
Net Debt-$14.6Mnet cash position
Cash & Equivalents$9.2M

Quality Metrics

Altman Z-Score-13.19
Piotroski F-Score2 / 9
FCF Margin-358,537.5%
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'22'23'24'25
FY2025: $8K
Diluted EPS-$0.86TTM
'22'23'24'25
FY2025: $-0.86

Dividend

No dividend

Capital Allocation

Capex Intensity42,575.0%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.